These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 12882525)

  • 1. Proteomics approaches to uncover the repertoire of circulating biomarkers for breast cancer.
    Shin BK; Wang H; Hanash S
    J Mammary Gland Biol Neoplasia; 2002 Oct; 7(4):407-13. PubMed ID: 12882525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Proteomics and breast cancer: a search for novel diagnostic and theragnostic biomarkers].
    Gilabert M; Audebert S; Viens P; Borg JP; Bertucci F; Gonçalves A
    Bull Cancer; 2010 Mar; 97(3):321-39. PubMed ID: 20202919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer classification by proteomic technologies: current state of knowledge.
    Lam SW; Jimenez CR; Boven E
    Cancer Treat Rev; 2014 Feb; 40(1):129-38. PubMed ID: 23891266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum proteome profiling of primary breast cancer indicates a specific biomarker profile.
    Böhm D; Keller K; Wehrwein N; Lebrecht A; Schmidt M; Kölbl H; Grus FH
    Oncol Rep; 2011 Nov; 26(5):1051-6. PubMed ID: 21837365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Profiling for Identification of Autoantibody Signatures in Diseases Using Protein Microarrays.
    Gupta S; Manubhai KP; Mukherjee S; Srivastava S
    Methods Mol Biol; 2017; 1619():303-315. PubMed ID: 28674893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomics for discovery of candidate colorectal cancer biomarkers.
    Alvarez-Chaver P; Otero-Estévez O; Páez de la Cadena M; Rodríguez-Berrocal FJ; Martínez-Zorzano VS
    World J Gastroenterol; 2014 Apr; 20(14):3804-24. PubMed ID: 24744574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical proteomics for cancer biomarker discovery and therapeutic targeting.
    Krieg RC; Paweletz CP; Liotta LA; Petricoin EF
    Technol Cancer Res Treat; 2002 Aug; 1(4):263-72. PubMed ID: 12625785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomics approaches to identify tumor antigen directed autoantibodies as cancer biomarkers.
    Imafuku Y; Omenn GS; Hanash S
    Dis Markers; 2004; 20(3):149-53. PubMed ID: 15502247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment: a novel resource for biomarker and therapeutic target discovery.
    Celis JE; Gromov P; Cabezón T; Moreira JM; Ambartsumian N; Sandelin K; Rank F; Gromova I
    Mol Cell Proteomics; 2004 Apr; 3(4):327-44. PubMed ID: 14754989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer.
    Li J; Zhang Z; Rosenzweig J; Wang YY; Chan DW
    Clin Chem; 2002 Aug; 48(8):1296-304. PubMed ID: 12142387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical proteomics in breast cancer: a review.
    Gast MC; Schellens JH; Beijnen JH
    Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomics for hepatocellular carcinoma marker discovery.
    Chignard N; Beretta L
    Gastroenterology; 2004 Nov; 127(5 Suppl 1):S120-5. PubMed ID: 15508075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cancer secretome, current status and opportunities in the lung, breast and colorectal cancer context.
    Schaaij-Visser TB; de Wit M; Lam SW; Jiménez CR
    Biochim Biophys Acta; 2013 Nov; 1834(11):2242-58. PubMed ID: 23376433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Proteomics and breast cancer].
    Mathelin C; Tomasetto C; Cromer A; Rio MC
    Gynecol Obstet Fertil; 2006 Dec; 34(12):1161-9. PubMed ID: 17123853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease.
    Smith JG; Gerszten RE
    Circulation; 2017 Apr; 135(17):1651-1664. PubMed ID: 28438806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody microarray analysis of the serum proteome in primary breast cancer patients.
    Böhm D; Keller K; Boehm N; Lebrecht A; Schmidt M; Kölbl H; Grus FH
    Cancer Biol Ther; 2011 Nov; 12(9):772-9. PubMed ID: 21885915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomics-based identification of RS/DJ-1 as a novel circulating tumor antigen in breast cancer.
    Le Naour F; Misek DE; Krause MC; Deneux L; Giordano TJ; Scholl S; Hanash SM
    Clin Cancer Res; 2001 Nov; 7(11):3328-35. PubMed ID: 11705844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic investigation on bio-corona of Au, Ag and Fe nanoparticles for the discovery of triple negative breast cancer serum protein biomarkers.
    Del Pilar Chantada-Vázquez M; López AC; Vence MG; Vázquez-Estévez S; Acea-Nebril B; Calatayud DG; Jardiel T; Bravo SB; Núñez C
    J Proteomics; 2020 Feb; 212():103581. PubMed ID: 31731051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of ganglioside GM2 activator playing a role in cancer cell migration through proteomic analysis of breast cancer secretomes.
    Shin J; Kim G; Lee JW; Lee JE; Kim YS; Yu JH; Lee ST; Ahn SH; Kim H; Lee C
    Cancer Sci; 2016 Jun; 107(6):828-35. PubMed ID: 27002480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multipronged quantitative proteomics reveals serum proteome alterations in breast cancer intrinsic subtypes.
    Gajbhiye A; Dabhi R; Taunk K; Jagadeeshaprasad MG; RoyChoudhury S; Mane A; Bayatigeri S; Chaudhury K; Santra MK; Rapole S
    J Proteomics; 2017 Jun; 163():1-13. PubMed ID: 28495502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.